The TNBC Foundation welcomes a passionate advocate and seasoned nonprofit leader dedicated to strengthening support and driving progress for the TNBC community ...
Medical Device Network on MSN
ASCO26: Abbott demonstrates MRD test benefit in TNBC recurrence
Abbott presented the data obtained from a prospective sub-study of the PARTNER trial at this year’s ASCO meeting in Chicago, ...
Events like this help bring together education, advocacy and community. We’re honored to partner with remarkable panelists to raise awareness and support patients and families navigating this disease.
AstraZeneca and Daiichi Sankyo's Datroway has been approved by the FDA for some previously untreated patients with metastatic ...
Triple Negative Breast Cancer (TNBC) is one of the most aggressive types of breast cancer. It’s the kind of breast cancer that doesn’t have estrogen receptors, progesterone receptors, and human ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results